These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 33297724

  • 1. Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.
    Huchting J.
    Antivir Chem Chemother; 2020; 28():2040206620976786. PubMed ID: 33297724
    [Abstract] [Full Text] [Related]

  • 2. Nucleosides for the treatment of respiratory RNA virus infections.
    Jordan PC, Stevens SK, Deval J.
    Antivir Chem Chemother; 2018; 26():2040206618764483. PubMed ID: 29562753
    [Abstract] [Full Text] [Related]

  • 3. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
    Tampere M, Pettke A, Salata C, Wallner O, Koolmeister T, Cazares-Körner A, Visnes T, Hesselman MC, Kunold E, Wiita E, Kalderén C, Lightowler M, Jemth AS, Lehtiö J, Rosenquist Å, Warpman-Berglund U, Helleday T, Mirazimi A, Jafari R, Puumalainen MR.
    Viruses; 2020 Dec 10; 12(12):. PubMed ID: 33322045
    [Abstract] [Full Text] [Related]

  • 4. Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases.
    Dinesh DC, Tamilarasan S, Rajaram K, Bouřa E.
    Curr Drug Targets; 2020 Dec 10; 21(2):105-124. PubMed ID: 31538891
    [Abstract] [Full Text] [Related]

  • 5. BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease.
    Taylor R, Kotian P, Warren T, Panchal R, Bavari S, Julander J, Dobo S, Rose A, El-Kattan Y, Taubenheim B, Babu Y, Sheridan WP.
    J Infect Public Health; 2016 Dec 10; 9(3):220-6. PubMed ID: 27095300
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Highly pathogenic RNA viral infections: challenges for antiviral research.
    Bray M.
    Antiviral Res; 2008 Apr 10; 78(1):1-8. PubMed ID: 18243346
    [Abstract] [Full Text] [Related]

  • 9. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
    Delang L, Abdelnabi R, Neyts J.
    Antiviral Res; 2018 May 10; 153():85-94. PubMed ID: 29524445
    [Abstract] [Full Text] [Related]

  • 10. Stealth nucleosides: mode of action and potential use in the treatment of viral diseases.
    Daifuku R.
    BioDrugs; 2003 May 10; 17(3):169-77. PubMed ID: 12749753
    [Abstract] [Full Text] [Related]

  • 11. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.
    Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, Gowen BB, Julander JG, Morrey JD.
    Antiviral Res; 2009 Jun 10; 82(3):95-102. PubMed ID: 19428599
    [Abstract] [Full Text] [Related]

  • 12. Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?
    Caly L, Wagstaff KM, Jans DA.
    Antiviral Res; 2012 Sep 10; 95(3):202-6. PubMed ID: 22750233
    [Abstract] [Full Text] [Related]

  • 13. Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.
    Christy MP, Uekusa Y, Gerwick L, Gerwick WH.
    J Nat Prod; 2021 Jan 22; 84(1):161-182. PubMed ID: 33352046
    [Abstract] [Full Text] [Related]

  • 14. Quasispecies, error catastrophe, and the antiviral activity of ribavirin.
    Graci JD, Cameron CE.
    Virology; 2002 Jul 05; 298(2):175-80. PubMed ID: 12127780
    [Abstract] [Full Text] [Related]

  • 15. The future of antivirals: broad-spectrum inhibitors.
    Debing Y, Neyts J, Delang L.
    Curr Opin Infect Dis; 2015 Dec 05; 28(6):596-602. PubMed ID: 26524332
    [Abstract] [Full Text] [Related]

  • 16. Acridones as antiviral agents: synthesis, chemical and biological properties.
    Sepúlveda CS, Fascio ML, García CC, D'Accorso NB, Damonte EB.
    Curr Med Chem; 2013 Dec 05; 20(19):2402-14. PubMed ID: 23521684
    [Abstract] [Full Text] [Related]

  • 17. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC, Evans DH.
    Antiviral Res; 2012 Nov 05; 96(2):169-80. PubMed ID: 22960154
    [Abstract] [Full Text] [Related]

  • 18. Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia.
    Hilgenfeld R.
    Future Med Chem; 2010 Jul 05; 2(7):1061-7. PubMed ID: 21426155
    [Abstract] [Full Text] [Related]

  • 19. Pleiotropic mechanisms of ribavirin antiviral activities.
    Hong Z, Cameron CE.
    Prog Drug Res; 2002 Jul 05; 59():41-69. PubMed ID: 12458963
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic Exploitation of Viral Interference.
    Kovesdi I, Bakacs T.
    Infect Disord Drug Targets; 2020 Jul 05; 20(4):423-432. PubMed ID: 30950360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.